Greg is the scientific founder of Vocxi Health. He began developing the MyBreathPrint® technology a decade ago after listening to pulmonologists speak about their frustrations and struggles with lung cancer diagnosis.  As CTO, Greg is responsible for directing and implementing the technical and scientific requirements for the MyBreathPrint system. He leads the continued development of key aspects of the sensing technology and continues to add to its intellectual property portfolio. Prior to Vocxi, Greg was the highest-level scientist at Boston Scientific — Senior Fellow. He brings a highly successful track record of developing practical technical solutions to highly complex problems. He is proud to be doing it again with the highly collaborative expert team at Vocxi as they bring to market this trailblazing new technology that has the potental to change the course of medical care.

Patents: 87